Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis
Top Cited Papers
- 1 November 2002
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 38 (2) , 111-121
- https://doi.org/10.1016/s0169-5002(02)00180-0
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Edatrexate (10‐ethyl‐deaza‐aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesotheliomaCancer, 1999
- Ifosfamide in malignant mesothelioma: a phase II studyLung Cancer, 1999
- Weekly systemic combination of cisplatin and interferon α2a in diffuse malignant pleural mesotheliomaLung Cancer, 1998
- Higher doses of α-interferon do not increase the activity of the weekly cisplatin-interferon combination in advanced malignant mesotheliomaEuropean Journal Of Cancer, 1997
- Two dose levels of ifosfamide in malignant mesotheliomaLung Cancer, 1996
- Mitoxantrone in malignant pleural mesothelioma: A study by the EORTC lung cancer cooperative groupEuropean Journal of Cancer and Clinical Oncology, 1991
- Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II studyCancer, 1991
- A phase II trial of ifosfamide/mesna with doxorubicin for malignant mesotheliomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Phase-II Study with the Combination of Cisplatin and Doxorubicin in Advanced Malignant Mesothelioma of the PleuraOncology Research and Treatment, 1988
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961